Cyclosporine suppresses rat hepatic cytochrome P450 in a time-dependent manner.BackgroundCyclosporine is a potent immunosuppressant known to selectively suppress specific cytochrome P450 (P450) isoforms following chronic therapy in the rat. Cyclosporine undergoes significant hepatic metabolism in the rat, primarily due to P450 3A isoforms. Hence, alterations in hepatic metabolism of cyclosporine may lead to changes in drug pharmacokinetics or pharmacodynamics. The purpose of this study was to examine the temporal effect of chronic cyclosporine dosing on P450 protein expression and metabolic activity in a rat model of chronic cyclosporine nephropathy.MethodsAdult male rats were administered cyclosporine 15mg/kg/day or vehicle 1 ml/kg/day by ...
Application of the widely used immunosuppressant (ISS) cyclosporine (CsA) is severely limited by a n...
The pharmacokinetic behavior of cyclosporine A (CyA), known as a potential immunosuppressive agent t...
Co-administration of the calcineurin inhibitor cyclosporine and the mTOR inhibitors sirolimus or eve...
Cyclosporine suppresses rat hepatic cytochrome P450 in a time-dependent manner.BackgroundCyclosporin...
textImmunosuppressant cyclosporine (CsA) is primarily metabolized by cytochrome P450 3A (CYP3A), an...
Parathion undergoes enzymatic oxidation by hepatic cytochrome P-450 (CYP450) enzymes to the active m...
Cyclosporine A, a potent calcineurin inhibitor, has been widely used in organ transplantation and in...
Based on the hypothesis that the therapeutic and toxic effects of cyclosporine (CSA) are dependent ...
Cyclosporine (CsA) suppresses drug metabolism by decreasing cytochrome P450 (P450) enzyme levels in ...
Components of whole blood and plasma are highly altered during the presentation of nephrotic syndrom...
PURPOSE. To develop an isolated perfused rat liver model to study the hepatic disposition of cyclosp...
Cyclosporine A is efficacious in the treatment of psoriasis when taken orally or injected intralesio...
International audienceIn vitro experiments have a high potential to improve current chemical safety ...
The nephrotoxicity of cyclosporin (CsA) continues to be a clinical problem that detracts from its ob...
Expression and activity of drug-metabolizing enzymes are de-creased in severe kidney disease; howeve...
Application of the widely used immunosuppressant (ISS) cyclosporine (CsA) is severely limited by a n...
The pharmacokinetic behavior of cyclosporine A (CyA), known as a potential immunosuppressive agent t...
Co-administration of the calcineurin inhibitor cyclosporine and the mTOR inhibitors sirolimus or eve...
Cyclosporine suppresses rat hepatic cytochrome P450 in a time-dependent manner.BackgroundCyclosporin...
textImmunosuppressant cyclosporine (CsA) is primarily metabolized by cytochrome P450 3A (CYP3A), an...
Parathion undergoes enzymatic oxidation by hepatic cytochrome P-450 (CYP450) enzymes to the active m...
Cyclosporine A, a potent calcineurin inhibitor, has been widely used in organ transplantation and in...
Based on the hypothesis that the therapeutic and toxic effects of cyclosporine (CSA) are dependent ...
Cyclosporine (CsA) suppresses drug metabolism by decreasing cytochrome P450 (P450) enzyme levels in ...
Components of whole blood and plasma are highly altered during the presentation of nephrotic syndrom...
PURPOSE. To develop an isolated perfused rat liver model to study the hepatic disposition of cyclosp...
Cyclosporine A is efficacious in the treatment of psoriasis when taken orally or injected intralesio...
International audienceIn vitro experiments have a high potential to improve current chemical safety ...
The nephrotoxicity of cyclosporin (CsA) continues to be a clinical problem that detracts from its ob...
Expression and activity of drug-metabolizing enzymes are de-creased in severe kidney disease; howeve...
Application of the widely used immunosuppressant (ISS) cyclosporine (CsA) is severely limited by a n...
The pharmacokinetic behavior of cyclosporine A (CyA), known as a potential immunosuppressive agent t...
Co-administration of the calcineurin inhibitor cyclosporine and the mTOR inhibitors sirolimus or eve...